Innate Pharma
ISIN FR0010331421
Innate Pharma has no current public net short positions above the disclosure threshold. The last disclosure was by Voleon Capital Management LP of 0.49% on 2022-01-28, reported to AMF.
Total net short positions over time
Previous position holders
No current positions above the disclosure threshold. Most recent disclosures per holder:
- Voleon Capital Management LP0.49%2022-01-28
- Citadel Advisors LLC0.47%2020-12-17
- Rubric Capital Management LP0.23%2020-09-16
- Numeric Investors LLC0.45%2018-11-08
- GSA Capital Partners LLP0.48%2018-04-12
- Marshall Wace LLP0.48%2018-01-02
- Oxford Asset Management LLP0.49%2017-09-15
- Citadel Advisors II LLC0.49%2017-08-17
- Millennium International Management LP0.48%2017-06-16
- WorldQuant LLC0.45%2017-05-03
Data is sourced from Autorité des Marchés Financiers, which publishes net short position disclosures on its public, free-to-access website. ShortsInsights.com republishes this information for convenience and may apply formatting, grouping, and cleaning that can introduce differences from the source. Data may be delayed, incomplete, or inaccurate, and may not reflect the most recent filings or corrections.
ShortsInsights.com is provided "as is" for informational purposes only and does not constitute investment, legal, or other advice. Users should verify any information directly with Autorité des Marchés Financiers before making decisions. ShortsInsights.com and its operators disclaim liability for errors, omissions, or actions taken in reliance on the information to the fullest extent permitted by law.